HF
XENT

HRT Financial’s Intersect ENT, Inc XENT Stock Holding History

HRT Financial’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33,576
Closed -$573K – 3961
2021
Q2 		$573K Buy
33,576
+23,489
+233% +$440K 0.01% 1635
2021
Q1 		$210K Buy
+10,087
New +$233K ﹤0.01% 2289
2020
Q4 		– Sell
-17,516
Closed -$285K – 2717
2020
Q3 		$285K Buy
+17,516
New +$317K 0.01% 1173
2018
Q4 		– Sell
-8,717
Closed -$250K – 790
2018
Q3 		$250K Buy
+8,717
New +$262K 0.04% 286

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's XENT Position: Q3 2021 in Review

HRT Financial sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 33,576 shares — an estimated $573K sold.

HRT Financial first reported a position in XENT in Q3 2018 and held it in 4 quarters. The position peaked at $573K in Q2 2021. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • HRT Financial reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • HRT Financial sold 33,576 Intersect ENT, Inc shares in Q3 2021, an estimated $573K.
  • HRT Financial first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 4 quarters.
  • HRT Financial's Intersect ENT, Inc position peaked at $573K in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.